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JHDM1B/FBXL10 is a nucleolar protein that represses
transcription of ribosomal RNA genes
David Frescas1, Daniele Guardavaccaro1, Florian Bassermann1, Ryo Koyama-Nasu1 & Michele Pagano1
JHDM1B is an evolutionarily conserved and ubiquitously
expressed member of the JHDM (JmjC-domain-containing his-
tone demethylase) family1–3. Because it contains an F-box motif,
this protein is also known as FBXL10 (ref. 4). With the use of
a genome-wide RNAi screen, the JHDM1B worm orthologue
(T26A5.5) was identified as a gene that regulates growth5. In the
mouse, four independent screens have identified JHDM1B as a
putative tumour suppressor by retroviral insertion analysis6–9.
Here we identify human JHDM1B as a nucleolar protein and
show that JHDM1B preferentially binds the transcribed region
of ribosomal DNA to repress the transcription of ribosomal
RNA genes. We also show that repression of ribosomal RNA genes
by JHDM1B is dependent on its JmjC domain, which is necessary
for the specific demethylation of trimethylated lysine 4 on histone
H3 in the nucleolus. In agreement with the notion that ribosomal
RNA synthesis and cell growth are coupled processes, we show a
JmjC-domain-dependent negative effect of JHDM1B on cell size
and cell proliferation. Because aberrant ribosome biogenesis and
the disruption of epigenetic control mechanisms contribute to
cellular transformation, these results, together with the low levels
of JHDM1B expression found in aggressive brain tumours, suggest
a role for JHDM1B in cancer development.
To begin assessing the biological function of JHDM1B, we inves-
tigated its cellular localization by using indirect immunofluorescence
analysis. The results presented in Fig. 1a and Supplementary Fig. 1a
show the localization of endogenous JHDM1B to the nucleolus of
human cell lines (HeLa and T98G) and non-immortalized, non-
transformed fibroblasts (IMR90). The nucleolar localization was
confirmed by simultaneous staining with the nucleolar protein
nucleophosmin/B23. Knockdown of JHDM1B by short interfering
RNA (siRNA) eliminated this nucleolar signal, demonstrating the
specificity of the immunostaining (Fig. 1a). JHDM1B has a putative
and evolutionarily conserved nucleolar localization signal (NoLS)
(Supplementary Fig. 1b). Comparison between wild-type JHDM1B
and a mutant lacking the NoLS (JHDM1B(NoLS)) revealed the
requirement of this basic amino-acid motif in the targeting of
JHDM1B to the nucleolus (Fig. 1b). Disruption of other domains
by point mutation or deletion failed to disrupt the localization of
JHDM1B to the nucleolar compartment (Supplementary Fig. 2).
Last, green fluorescent protein (GFP)-tagged JHDM1B localized to
the nucleolus of living HeLa cells (Supplementary Fig. 3). Taken
together, these data show that JHDM1B is a nucleolar protein, and
its subcellular localization is dependent on the presence of a NoLS
motif.
The nucleolar localization of JHDM1B, together with the presence
of a CXXC zinc-finger DNA-binding domain, suggested that this
protein might bind ribosomal DNA. During mitosis, rDNA-binding
proteins, such as RNA polymerase I (pol I) and the pol I transcription
factor UBF (upstream binding factor), remain associated with
chromosomes and display discrete foci at nucleolar organizing
regions (NORs)10, which mark transcriptionally competent nuc-
leation points for nucleoli from the previous interphase. JHDM1B
localized together with UBF at NORs inmitotic cells (Supplementary
Figs 4 and 5). Moreover, JHDM1B continued to localize to the
nucleolar compartment after pretreatment with Triton X-100
(Supplementary Fig. 6), similar to UBF11, suggesting stable asso-
ciation with rDNA.
To confirm the binding of JHDM1B to rDNA and to obtain a
high-resolution map for this binding, we performed chromatin
immunoprecipitation (ChIP) assays followed by quantitative real-
time polymerase chain reaction (PCR) using primer pair sets that
span the entire human rDNA repeat12. Mapping of JHDM1B binding
throughout the rDNA locus showed that JHDM1B bound mainly to
the transcribed region of rDNA, with particular enrichment at 8
kilobases (kb) (Fig. 1c–e). The specificity of the binding to rDNA
was confirmed by the lack of JHDM1B enrichment on the glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) promoter and by the
fact that a DNA-binding mutant, JHDM1B(CXXC), failed to bind to
the 8-kb region (Fig. 1e, f). CXXC zinc-finger domains specifically
recognize and bind unmethylated CpG-rich regions13. This binding
was confirmed in vitro for JHDM1B14. CpG-island prediction by the
bioinformatics program cpgplot (http://www.ebi.ac.uk/emboss/
cpgplot) and previously reported biochemical studies15 show enrich-
ment of CpG-rich regions in rDNA over the transcribed region of
rDNA (Supplementary Fig. 7), where JHDM1B binds. Thus,
JHDM1B binds across the transcriptionally competent region of
the rDNA repeat, with particular affinity for regions containing ele-
vated CpG frequency.
To determine whether JHDM1B has a function in regulating
rDNA transcription in vivo, we measured the levels of the 45S pre-
ribosomal RNA by quantitative reverse transcriptase-mediated PCR
(qRT–PCR). Silencing of JHDM1B by siRNA resulted in a significant
increase in the expression of pre-rRNA compared with control
siRNA (Fig. 2a), suggesting that JHDM1B is a repressor of rDNA
transcription. Accordingly, we observed that cells expressing exogen-
ous JHDM1B displayed a marked decrease in pre-rRNA synthesis
compared with mock-transfected cells (Fig. 2b).
To investigate the domains required for JHDM1B-mediated
repression of rRNA in vivo, we measured pre-rRNA levels in cells
expressing JHDM1B mutants. Loss of the PHD finger or the F-box
domain resulted in continued repression by JHDM1B, whereas loss
of the NoLS or the CXXC zinc-finger blocked this transcriptional
repression (Fig. 2b). We also found that the JmjC histone demethy-
lase domain was required for the transcriptional repression of rDNA
by JHDM1B (Fig. 2b).Moreover, a significant portion of cells expres-
sing JHDM1B also failed to incorporate BrUTP within the nucleolus
in a JmjC-domain-dependent manner (Fig. 2c). Taken together,
these data show that JHDM1B represses rDNA transcription. This
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repression requires the NoLS motif (to allow nucleolar localization)
and the CXXC zinc-finger domain (to bind DNA). In addition, the
repressive activity of JHDM1B required its JmjC domain.
To investigate the requirement for the JmjC domain, we addressed
previous studies showing that JHDM1A demethylates dimethylated
lysine 36 on histone 3 (H3K36me2) by means of this motif1. We
conducted an immunofluorescence analysis in HeLa cells transfected
with constructs encoding JHDM1A or JHDM1B by using an anti-
body against H3K36me2, and we found that forced expression of
JHDM1A significantly decreased the levels ofH3K36me2, as reported
previously1, whereas JHDM1B had no effect (Supplementary Fig. 8).
JHDM1B was also unable to produce any significant changes in
the methylation status of H3K36me3, H3K9me3, H3K27me3 or
H3K4me2 (Supplementary Fig. 9). In contrast, JHDM1B overexpres-
sion resulted in a significant decrease in H3K4me3 levels, and this
decrease required the presence of the JmjC domain (Fig. 3a, b). The
specific reduction of H3K4me3 levels by JHDM1B was confirmed by
immunoblotting (Fig. 3c, d). Last, incubation of core histones with
immunopurified JHDM1B confirmed in vitro the ability of JHDM1B
to demethylate H3K4me3 (Supplementary Fig. 10). Taken together,
these results demonstrate that JHDM1B is a histone demethylase that
catalyses the demethylation of H3K4me3. This finding is significant
because active rRNA genes are reported to display active, euchro-
matic features that include H3K4me3 (refs 16, 17).
Because the decrease in global H3K4me3 levels was probably due to
leakage of exogenous JHDM1B into the nucleoplasm, we investigated
whether local changes inH3K4 trimethylation levels occuron rDNAby
using an anti-H3K4me3 antibody inChIP analysis. Downregulation of
JHDM1B resulted in an increase inH3K4me3on rDNA, particularly in
the promoter region (42.9 kb) (Fig. 3e). Accordingly, we found a sig-
nificant decrease in the levels of H3K4me3 at the rDNA locus in cells
ectopically expressing JHDM1B (Fig. 3f).
Interestingly, ectopic expression of JHDM1B decreased the occu-
pancy of UBF at rDNA regions previously reported to be enriched for
the protein12 (Fig. 3g). Similarly, JHDM1B expression decreased the
amount of chromatin-bound UBF in a JmjC-dependent manner,
whereas depletion of JHDM1B increased the binding of UBF to chro-
matin (Supplementary Figs 11 and 12).
EV
JHDM1B
(anti-Flag)
JHDM1B JHDM1B(NoLS)
B23
DNA
ba
JHDM1B
B23
DNA
2.5 µm 2.5 µm 2.5 µm 2.5 µm 2.5 µm
Control siRNA JHDM1B siRNA
0
5
10
15
20
25
30
Transcribed Non-transcribed
d
rDNA base
number (kb)
rDNA base
number (kb)
1 4 8 13 18 27 32 42 42.9
1 4 8 13 18 27 32
1 8 32 GAPDH
42 42.9
28S5.8S18S
Transcribed Non-transcribed Promoter
Promoter
c 45S
rDNA base number (kb)
0
2
4
6
8
10
e
0
5
10
15
20
25
30
EV JHDM1B
(CXXC)
f
A
nt
i-F
la
g 
(f
ol
d 
en
ric
hm
en
t)
A
nt
i-F
la
g 
(f
ol
d 
en
ric
hm
en
t)
A
nt
i-J
H
D
M
1B
 v
er
su
s 
lg
G
 c
on
tr
ol
(f
ol
d 
en
ric
hm
en
t)
JHDM1B
Figure 1 | JHDM1B localizes to the nucleolus and associates with rDNA.
a, Indirect immunofluorescence analysis of endogenous JHDM1B in HeLa
cells treated with control siRNA oligonucleotides or oligonucleotides
targeting JHDM1B mRNA. Cells were stained with antibodies against
JHDM1B and nucleophosmin/B23 and DAPI (to visualize DNA), as
indicated. b, Indirect immunofluorescence analysis of HeLa cells transfected
with an empty vector (EV) or constructs encoding Flag-tagged JHDM1B or
JHDM1B(NoLS), as indicated. Cells were stainedwith an anti-Flag antibody,
an antibody against B23 and DAPI. c, Schematic representation of a single
human rDNA repeat. d, JHDM1B binds across the transcriptionally
competent region of rDNA. Enrichment of rDNA obtained with anti-Flag
antibody as determined by ChIP analysis using chromatin prepared from
HeLa cells transfectedwith Flag–EV (open columns) or a construct encoding
Flag-tagged JHDM1B (filled columns). DNA binding was quantified by real-
time PCR with primer sets at indicated regions along the rDNA. The value
given for the amount of PCR product present in EV-transfected cells was set
at 1. e, Analysis of endogenous JHDM1B enrichment on rDNA and the
GAPDH promoter by ChIP from chromatin of HeLa cells. JHDM1B
enrichment (filled columns) was quantified by real-time PCR with the
indicated primer sets. The value given for the amount of PCR product
present from ChIP with control IgG (anti-haemagglutinin; open columns)
was set as 1. f, ChIP experiment for enrichment of rDNA at 8 kb (filled
columns) and the GAPDH promoter (open columns) was performed as in
d. All error bars represent s.d. (n5 3).
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Because the synthesis of rRNAs and cell growth are coupled
processes18, we investigated whether JHDM1B affected cell size and
cell proliferation. Forward scatter analysis showed that HeLa cells
exogenously expressing JHDM1B were significantly smaller than
control or JHDM1B(JmjC)-expressing cells (Fig. 4a). This effect also
required the NoLS and the CXXC zinc-finger domains but not the
PHD domain (Supplementary Fig. 13). Cells expressing JHDM1B
also incorporated about 40% less bromodeoxyuridine (BrdU) than
control cells, reflecting a smaller population of cells in S phase
(Fig. 4b). Conversely, cells in which JHDM1B was silenced were
significantly larger than control cells and showed a 1.67-fold increase
in BrdU incorporation (Fig. 4c ,d). Accordingly, JHDM1B-depleted
cells proliferated at a faster rate than control HeLa cells (Fig. 4e).
Taken together, these data suggest that JHDM1B-mediated modu-
lation of rRNA gene expression influences cell growth and prolifera-
tion. Interestingly, under conditions in which rRNA production has
been shown to decrease, such as during serum deprivation19, the
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Figure 2 | JHDM1B represses transcription of rRNA genes via the JmjC
domain. a, qRT–PCR analysis of pre-rRNA (filled columns) and JHDM1B
mRNA (open columns) from HeLa cells transfected with siRNA targeting
JHDM1B compared with control. The value given for the amount of pre-
rRNA PCR product present in control cells was set as 1. The value given
for the amount of JHDM1BPCRproduct present in control cells was set at 5.
b, Top: qRT–PCR analysis of pre-rRNA in HeLa cells retrovirally infected
with an empty vector (EV) or constructs encoding wild-type JHDM1B or the
indicated mutants. The value given for the amount of pre-rRNA present in
empty vector (EV) transfected cells was set as 1. Bottom: expression of
JHDM1B proteins, as analysed by immunoblotting (a-tubulin was used as a
loading control). c, Graphical representation of BrUTP incorporation in the
nucleolus ofHeLa cells transfectedwith EVor constructs encoding JHDM1B
or JHDM1B(JmjC). All error bars represent s.d. (n5 3).
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Figure 3 | JHDM1B demethylates H3K4me3 on the rDNA locus. a, Indirect
immunofluorescence analysis of H3K4me3 levels in HeLa cells transfected
with vectors encoding JHDM1B or JHDM1B(JmjC). Cells were stained with
antibodies against Flag and H3K4me3, and with DAPI, as indicated.
b, Quantification of three experiments performed as in a. The value given for
H3K4me3 present in EV-transfected cells was set at 100%. Error bars
represent s.d. (n5 3). c, Levels of methylated histone H3 in HeLa cells
infected with an empty retrovirus (EV) or with retroviruses encoding
JHDM1B or JHDM1B(JmjC) and analysed by immunoblotting with
antibodies against the indicated proteins. The bottom panel shows core
histones stained with Ponceau red. d, Densitometric quantification of
three experiments performed as in c. The value given for H3K4me3
present in EV-transfected cells was set at 100%. Error bars represent s.d.
(n5 3). e, HeLa cells were transfected with control siRNA (open columns)
or JHDM1B siRNA (filled columns) oligonucleotides, and ChIPs were
performed as in Fig. 1e. f, Analysis of H3K4me3 enrichment on rDNA,
quantified as in e, using chromatin from 293T cells transfectedwith Flag–EV
(open columns) or a construct encoding Flag–JHDM1B (filled columns).
g, JHDM1B expression induces the dissociation of UBF from rDNA.
Analysis of UBF enrichment on rDNA, quantified as in e, using chromatin
from HeLa cells transfected with empty vector (open columns) or a
construct encoding Flag–JHDM1B (filled columns). Error bars in
e–g represent s.d. (n5 3).
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amount of chromatin-bound JHDM1B increased, whereas serum re-
addition transiently abolished this binding (Supplementary Fig. 14),
suggesting that the binding of JHDM1B to rDNA is regulated by
mitogens.
Actively proliferating cells transcribe high levels of rDNA and
often show an increase in nucleolar number18. Whereas about
60% of HeLa cells possessed five or six nucleoli, cells ectopically
expressing JHDM1B had a substantial nucleolar contraction, with
most JHDM1B-positive cells possessing three or fewer nucleoli per
cell (Fig. 4f). Consistent with the inability of JHDM1B(JmjC) and
JHDM1B(NoLS) to repress rRNA expression was the observation
that these mutants were unable to induce nucleolar contraction
(Fig. 4f). Knockdown of JHDM1B resulted in the generation of nuclei
with disorganized nucleoli; the number of nucleoli in JHDM1B
siRNA-treated cells exceeded seven per nucleus (Figs 1a and 4g,
and Supplementary Fig. 15).
A recent study has established a NOR-based index as a marker for
grading and staging astrocytic lesions of the brain20. The number of
NORs was found to rise in parallel with the grade, stage and prolif-
erative state of the tumour. To investigate a potential involvement of
JHDM1B in human cancer, we searched the Oncomine and the NIH-
GEO online databases for differential JHDM1B expression in normal
versus tumorigenic tissues21,22. Expression of JHDM1B, but not that
of JHDM1A, was significantly decreased in the most common and
the most aggressive of the primary brain tumours, glioblastoma
multiform (GBM), relative to normal brain tissue (Fig. 4h and
Supplementary Fig. 16). This decrease in JHDM1B expression was
correlated with brain tumour type and tumour grade (Fig. 4i). Taken
together, these results suggest that the decreased expression of
JHDM1Bmight contribute to the increased cell growth/proliferation
and the number of NORs in GBM tumours, possibly resulting from
aberrant regulation of rRNA expression.
Thus, we show here that JHDM1B localizes to the nucleolus and
provides a fundamental function for silencing rRNA genes in a man-
ner dependent on its JmjC domain. Our findings suggest that this
activity involves the demethylation of H3K4me3 at the rDNA locus,
although we cannot exclude additional nucleolar, non-histone
targets. Ribosome biogenesis is a highly coordinated process that
ensures proper cell growth and proliferation by supporting the syn-
thesis of proteins. Deregulation of this process has been linked to
multiple forms of human disease, including cancer. Our study pro-
vides critical insight into the role of aberrant ribosome biogenesis
and epigenetic mechanisms to cellular transformation. We propose
JHDM1B as an addition to the list of tumour suppressors, such as p53
and pRb, that negatively regulate rRNA gene expression18.
METHODS SUMMARY
RNA interference. HeLa cells were transfected by using HiPerFect transfection
reagent (Qiagen), in accordance with the manufacturer’s protocol, with either a
single siRNAoligonucleotide (59-AGGCAAGUUUAACCUCAUG-39) or a pool of
four siRNA oligonucleotides (59-GCAAUAAGGUCACUGAUCAUU-39, 59-
GACCUCAGCUGGACCAAUAUU-39, 59-GGGAGUCGAUGCUUAUUGAUU-
39 and 59-CAGCAUAGACGGCUUCUCUUU-39) targeting human JHDM1B
(Dharmacon). Direct comparison of the pool of oligonucleotides and the single
oligonucleotide (which was not present in the pool) showed identical results.
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Figure 4 | JHDM1B inhibits cell growth and proliferation. a, Cell size was
determined by fluorescence-activated cell sorting (FACS; forward scatter) in
HeLa cells retrovirally infected with empty vector (blue) or constructs
encoding wild-type JHDM1B (red) or JHDM1B(JmjC) (green), as indicated.
b, Percentage of BrdU-positive HeLa cells transfected with EV or constructs
encoding Flag-tagged JHDM1B or JHDM1B(JmjC). c, Cell size was
determined by FACS (forward scatter) in HeLa cells transfected with control
siRNA (blue) or JHDM1B siRNA (red) oligonucleotides. d, Percentage of
BrdU-positive HeLa cells transfected as indicated. e, Proliferation of HeLa
cells (transfected with control siRNA (blue) or JHDM1B siRNA (red)
oligonucleotides) over a five-day period. f, Analysis of the number of
nucleoli (determined by immunofluorescence with anti-B23 antibody) in
HeLa cells transfected with EV or with constructs encoding Flag-tagged
JHDM1B or the indicated JHDM1Bmutants.White columns, three or fewer
nucleoli; grey columns, four nucleoli; black columns, five or six nucleoli.
g, Experiment performed as in f except that siRNA oligonucleotides against
JHDM1B were compared with the control. White columns, three or fewer
nucleoli; grey columns, four nucleoli; black columns, five or six nucleoli; red
column, seven or more nucleoli. h, Data from ref. 21 (provided by
Oncomine) reanalysed to show expression levels of JHDM1B in normal
brain (NB), glioblastomas multiform (GBM), astrocytic tumours (AT),
oligodendrogliomas (OD) and anaplastic oligoastrocytomas (AO). i, Data
from ref. 22 (provided byNIH-GEO) reanalysed to show expression levels of
JHDM1B in grade III and grade IV brain tumours (AA, anaplastic
astrocytoma; AM, anaplastic mixed oligoastrocytoma). P, 0.040; t5 1.770.
Where present, error bars represent s.d. (n5 3).
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Transcription analysis by qRT–PCR. RNA was extracted with the use of the
RNeasy kit (Qiagen), and reverse transcriptions were performed as described
previously12. qRT–PCR analysis was performed in accordance with standard
procedures with SYBR Green mix (Bio-Rad). Primer sequences used to detect
pre-rRNA and the housekeeping gene ARPP P0 were as reported12. The primer
pairs used for the quantification of pre-rRNA recognize the 59 external tran-
scribed spacer (59 ETS), and because the 59 ETS is processed rapidly during
transcription, it accurately reflects the rate of RNA pol I transcription12. The
sequences used for JHDM1B were 59-GAGGAGAAGAAGAAGGTGAAG-39 and
59-TTGATGGGCTGCTGGTTC-39.
Indirect immunofluorescence. Cells were plated and cultured on chambered
glass tissue-culture slides (BD Falcon) with complete medium. For immuno-
fluorescence, cells were washed in PBS, fixed and permeabilized in 100% meth-
anol at 220 uC for 10min, and then incubated with the primary antibodies for
1 h at 25 uC in 0.5% Tween 20 in PBS (0.5% TBST). Slides were washed three
times in 0.5% TBST for 5min and incubated with secondary antibodies, diluted
1:1,000. 49,6-Diamidino-2-phenylindole (DAPI; Molecular Probes) was
included to reveal nuclei. Slides were washed in PBS and subsequently mounted
with Aqua Poly/Mount (Polysciences). Images were acquired with a Nikon
Eclipse E800 fluorescence deconvolution microscope. For pre-extraction, cells
were rinsed in PBS and incubated in 0.5%Triton X-100 for 5min on ice followed
by methanol fixation at220uC, permeabilization, and the immunofluorescence
procedure described above. Fluorescence quantification was determined with
ImageJ software (NIH).
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Cell culture. HeLa, T98G, 293T, GP-293 and IMR90 cells were cultured as
described previously23,24.
Antibodies. A polyclonal antibody against JHDM1B was generated by immun-
izing rabbits with a peptide containing amino-acid residues 800–1000 of human
JHDM1B. Rabbit polyclonal antibodies were as follows: anti-Flag (F7425;
Sigma), anti-haemagglutinin (anti-HA) (71-5500; Zymed), anti-di-methyl
H3K36 (07-274; Upstate), anti-di-methyl H3K4 (07-030; Upstate), anti-tri-
methyl H3K4 (05-745; Upstate), anti-tri-methyl H3K9 (07-523; Upstate),
anti-tri-methyl H3K27 (07-449; Upstate), anti-tri-methyl H3K36 (ab9050;
Abcam), anti-Alexa Fluor 568 (A11036; Molecular Probes) and anti-phospho-
H3 (Ser 10) (06-570; Upstate). Mouse monoclonal antibodies were as follows:
anti-M2 Flag (F3165; Sigma), anti-nucleophosmin (32-5200; Zymed), anti-UBF
(sc-13125; Santa Cruz Biotechnology), anti-a-tubulin (32-2500; Zymed), anti-
JHDM1B (H00084678-M09; Abnova), anti-GFP (A-11121; Molecular Probes),
anti-BrdU (347580 (7580); BD) and anti-Alexa Fluor 488 (A21121; Molecular
Probes).
Chromatin immunoprecipitations. ChIP assays were conducted as described
previously23. The polyclonal antibody against JHDM1B was used for ChIP ana-
lysis of endogenous JHDM1B. anti-HA or anti-GFP antibodies were used as
controls. Primer sequences for rDNA were as reported12. GAPDH sequences
were: 59-TCCACCACCCTGTTGCTGTA-39 and 59-ACCACAGTCCATGCC-
ATCAC-39.
Cell proliferation and FACS analysis. HeLa cells were transfected with siRNA
oligonucleotides for two consecutive days, as described in the Methods
Summary. At 48 h after the second transfection, an 80% confluent dish was
trypsinized, split into five dishes and retransfected with siRNA oligonucleotides,
in accordance with the long-term gene-silencing technique from the manufac-
turer (Qiagen). Cells were collected daily for five days and analysed by standard
counting methods. FACS and forward scatter analysis were conducted as
described previously23–25.
Solubilized chromatin purification. Purification of solubilized chromatin frac-
tions was performed as described previously26.
BrdU and BrUTP incorporation. BrdU incorporation was performed as
described previously27. For BrUTP incorporation, BrUTP (Molecular Probes)
was added to a FuGENE 6 and 20-mMHEPES mixture (1:10) to a final concen-
tration of 1mM for 15min at 25 uC, as described by Roche Molecular
Biochemicals. During this short period, BrUTP specifically highlights transcrip-
tionally active nucleoli, and no BrUTP incorporation is observed outside the
nucleoli28,29. Slides were washed in PBS and the BrUTP–FuGENE 6 mixture was
added to cells. Cells were incubated at 4 uC for 15min, washed briefly in PBS and
then incubated at 37 uC in culture medium for 5min. Cells were processed for
immunofluorescence analysis, as stated above, and an anti-BrdU antibody was
used for detection. The BrdU and nucleolar-BrUTP-positive cells were analysed
with standard counting methods.
Data mining. Gene expression data on JHDM1A and JHDM1B were retrieved
from the Oncomine website (http://www.oncomine.org) and the National
Institutes of Health (NIH) Gene expression omnibus (GEO) (http://
www.ncbi.nlm.nih.gov/geo/). Data from two brain cancer studies were used
for statistical calculations. Bredel et al.21 includes analysis of 50 human gliomas
of various histogenesis with the use of cDNAmicroarrays. Data were reanalysed
in GraphPad software to show expression levels of JHDM1B and JHDM1A.
Additional details of the study, including the pathological and clinical data,
are available at Oncomine or on the Cancer Research journal website. Data from
the second study were from an analysis of grade III and IV gliomas of various
histological types22. These data were gathered as part of the NIH Neuroscience
Microarray Consortium (http://arrayconsortium.tgen.org). Data were acquired
and reanalysed with a signal value threshold of 15,000, using GraphPad software
to show expression levels of JHDM1B and to determine P and one-tailed t-test
values.
In vitro histone demethylation assay. In vitro demethylation assays were con-
ducted as described previously30. In brief, core histones were incubated with
Flag-immunopurified JHDM1B from 293T cells in demethylation buffer
(50mM Tris-HCl pH8.0, 50mM KCl, 10mM MgCl2, 1mM a-oxoglutarate,
40mM FeSO2, 2mM ascorbic acid) at 37 uC. Core histones (2mg) were incu-
bated for 30min with Flag-immunopurified JHDM1B in a volume of 30 ml.
Reaction mixtures were analysed by western blotting. Quantification by densi-
tometry was performed with ImageJ (NIH) software.
FRAP (fluorescence recovery after photobleaching) analysis. HeLa cells were
plated, transfected with JHDM1B–pEGFP-N1 (Clontech Laboratories) by
FuGENE 6 (Roche) and observed in LabTek II chambers (Nalgene). Selective
photobleaching of the nucleolus was conducted on an LSM 510 microscope
(Zeiss) with laser excitation at 488 nm for GFP and a 633, 1.2 numerical aper-
ture, oil-immersion objective, as described previously31. JHDM1B–GFP fluor-
escence for each image in the sequence was determined with ImageJ software
(NIH).
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